Research News

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression

Intestinal metaplasia (IM), often symptomless, poses a six-fold increased risk of stomach cancer. In this cross-institutional study, co-led by N2CR member Prof Jimmy So, researchers have identified 26 IM driver genes pivotal in the transition to cancer. The findings, published in Cancer Cell, was the world’s largest genomic survey of over 1,100 samples of IM. This significant discovery offers insight into the processes that control the transformation to stomach cancer, providing a crucial opportunity for early detection and focused prevention.

Read more: https://pubmed.ncbi.nlm.nih.gov/37890493/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Predicting CLL Treatment with BCL-2 Dependence

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the buildup …

Read More →
Research News

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera

Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …

Read More →
Research News

Efficacy of Combined Pembrolizumab and Bevacizumab in Platinum-Resistant Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is common in South China and parts of Southeast Asia. Despite treatment, 20-30% of patients relapse within …

Read More →